Ann: Increased Scheme Consideration from Pfizer, page-186

As a few have said prior. The delays may actually be helping us right now.

We'll get to see revenue from this quarter and potential news regarding FDA. I still think new deals may be on hold for now (I'd be happy to be surprised), but the big one is if anyone else is going to put a bid in.

Exciting times all, still a lot to be played out. I've held for years and am happy to do so for a few more to try and see this through.